Sponsor

Ciusss de L'Est de l'Île de Montréal

Clinical research sponsor

Published trials14
Recruiting shown2
Roles1
SourceClinicalTrials.gov

Clinical trials

14 shown
Home-Based tDCS for Depression in BPDNCT06972368 · lead sponsor · 2026-01-01
RECRUITING
RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic DisordersNCT05704582 · lead sponsor · 2023-02-01
RECRUITING
Combining Virtual Reality and Hypnosis to Alleviate Chronic Pain in Elderly Patients with Hand ArthritisNCT06833905 · lead sponsor · 2025-04-01
NOT_YET_RECRUITING
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective SurgeryNCT06500143 · lead sponsor · 2024-10-09
COMPLETED
Avatar Therapy in Virtual Reality for Treatment-Resistant Major Depressive Disorder: A Pilot StudyNCT07112261 · lead sponsor · 2024-08-01
ACTIVE_NOT_RECRUITING
Thoracic Paravertebral Block Anesthesia for Breast Cancer SurgeryNCT05711030 · lead sponsor · 2022-11-04
UNKNOWN
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 DiabetesNCT05385211 · lead sponsor · 2022-04-30
COMPLETED
ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology TreatmentNCT05787145 · lead sponsor · 2021-03-10
UNKNOWN
Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to PaclitaxelNCT04237090 · lead sponsor · 2020-02-14
COMPLETED
Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health DisordersNCT05726617 · lead sponsor · 2019-09-24
UNKNOWN
Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory HallucinationsNCT04054778 · lead sponsor · 2019-04-01
UNKNOWN
Citalopram Titration in Early Non-responder Patients With Major Depressive DisordersNCT03899285 · lead sponsor · 2018-01-08
COMPLETED
Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant SchizophreniaNCT03585127 · lead sponsor · 2017-03-01
COMPLETED
Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in SchizophreniaNCT03148639 · lead sponsor · 2015-09-01
COMPLETED

Sponsor roles

lead sponsor14

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.